Abstract
Thyroid disorders are common. At least 5% of the adult population in Western countries have hypothyroidism, hyperthyroidism, goitre or a nodule in the thyroid. Most of those with a goitre or nodule are euthyroid, but laboratory confirmation of this is required. Laboratory documentation of abnormal thyroid function is very important, because treatment, whether for hyperthyroidism or hypothyroidism, is often lifelong and therefore should not be based on clinical opinion alone. Suspected thyroid disease is more common than true dysfunction. The tired, depressed, overweight, nervous, infertile, irritable, thin and comatose are all at risk of having their thyroid function tested.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Shimaoka, K. (1973) Toxic adenoma of the thyroid with triiodothyronine as the principal circulating thyroid hormone. Acta Endocrinol., 43, 285–93.
Popma, B.H,. Cloutier, M.D. and Hayles, A.B. (1973) Thyroid nodule producing T3 toxicosis in a child. Mayo Clin. Proc., 48, 273–5.
Hollander, CS., Shenkman, L., Mitsuma, T. et al. (1971) Hypertriiodothyroninaemia as a premonitary manifestation of thyrotoxicosis. Lancet, 2, 731–3.
Hollander, CS., Mitsuma, T., Nihei, N. et al. (1971) Clinical and laboratory observations in cases of triiodothyronine toxicosis confirmed by radioimmunoassay. Lancet, 1, 731–3.
Shenkman, L., Mitsuma, T., Blum, M. et al. (1972) Recurrent hyperthyroidism presenting as triiodothyronine toxicosis. Ann. Intern. Med., 77, 410–13.
Sung, L.C and Cavalieri, R.R. (1973) T3 toxicosis due to metastatic thyroid carcinoma. J. Clin. Endocrinol. Metab., 36, 215–17.
Engler, D., Donaldson, E.B., Stockigt, J.R. et al. (1978) Hyperthyroidism without triiodothyronine excess: an effect of severe non-thyroidal illness. J. Clin. Endocrinol., Metab., 46, 77–82.
Caplan, R.H., Pagliara, A.S. and Wickus, G. (1980) Thyroxine toxicosis. A common variant of hyperthyroidism. JAMA, 244, 1934–8.
Ogbuawa, O. and Johnson, R. (1980) T4-toxicosis storm in pernicious anemia. Arch. Intern. Med., 140, 1245–6.
Evered, D., Ormston, B.J., Smith, P.A. et al. (1973) Grades of hypothyroidism. Br. Med. J., 1, 657–62.
Bermudez, F., Surks, M.I. and Oppenheim-er, J.H. (1975) High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease. J. Clin. Endocrinol. Metab., 41, 27–40.
Chopra, I.J., Chopra, U., Smith, S.R. et al. (1975) Reciprocal changes in serum concentrations of 3,3’,5’-triiodothyronine (reverse T3) and 3,3’,5-triiodothyronine (T3) in systemic illness. J. Clin. Endocrinol. Metab., 41, 27–40.
Croxon, M.S. and Ibbertson, H.K. (1977) Low serum triiodothyronine (T3) and hypothyroidism in anorexia nervosa. J. Clin. Endocrinol. Metab., 44, 167–74.
Chopra, I.J., Solomon, D.H., Hepner, G.W. et al. (1979) Misleadingly low free thyroxine index and usefulness of reverse triiodothyronine measurement in nonthyroidal illness. Ann. Intern. Med., 90, 905–12.
Wood, D.G., Cyrus, J. and Samols, E. (1980) Low T4 and low FT4I in seriously ill patients: concise communication. J. Nucl. Med., 21, 432–5.
Bayer, M.F. and McDougall, I.R. (1982) Free thyroxine by solid phase radioimmunoassay: improvement in the laboratory diagnosis of thyroid status in severely ill patients. Clin. Chim. Acta, 118, 209–18.
Gavin, L.A., Rosenthal, M. and Cavalieri, R.R. (1979) The diagnostic dilemma of isolated hyperthyroxinemia in acute illness. JAMA, 242, 251–3.
Cohen, K.L. and Swigar, M.E. (1979) Thyroid function screening in psychiatric patients. JAMA, 242, 254–7.
Spratt, D.I., Pont, A., Miller, M. et al. (1982) Hyperthyroxinemia in patients with acute psychiatric disease. Am. J. Med., 73, 41–8.
Burr, W. A., Ramsden, D.B., Evans, S.E. et al. (1977) Concentration of thyroxine-binding globulin: value of direct assay. Br. Med. J., 1, 485–8.
Dos Remedios, L.V., Weber, P.M., Feldman, R. et al. (1980) Detecting unsuspected thyroid dysfunction by the free thyroxine index. Arch. Intern. Med., 140, 1045–9.
Ingbar, S.H., Braverman, L.E., Dawber, N.A. et al. (1965) A new method for measuring the free thyroxine hormone in human serum and an analysis of the factors that influence its concentration. J. Clin. Invest., 44, 1679–89.
Sterling, K. and Brenner, M.A. (1966) Free throxine in human serum; simplified measurement with the aid of magnesium precipitation. J. Clin, Invest., 45, 153–63.
Kaptein, E.M., Macintyre, S.S., Weiner, J.M. et al. (1981) Free thyroxine estimates in nonthyroidal illnesses: comparison of eight methods. J. Clin, Endocrinol. Metab., 52, 1073–7.
Szpunar, W.E., Block, M., Bernarz, M.N. et al. (1980) Clinical evaluation of three free-thyroxine assays. J. Nucl. Med., 21, 576–8.
Witherspoon, L.R., Shuler, S.E., Garcia, M.M. et al. (1980) An assessment of methods for the estimation of free thyroxine. J. Nucl. Med., 21; 529–39.
Melmed, S., Geola, F.L., Reed, A.W. et al. (1982) A comparison of methods for assessing thyroid function in nonthyroidal illness. J. Clin, Endocrinol. Metab., 54, 300–6.
Bayer, M.F. (1983) Free thyroxine results are affected by albumin concentrations and nonthyroidal illness. Clin. Chim. Acta, 130, 391–6.
Bayer, M.F. and McDougall, I.R. (1980) Radioimmunoassay of free thyroxine in serum. Comparison with clinical findings and results of conventional thyroid function tests. Clin. Chem., 26, 1186–92.
Mcdougall, I.R., Bayer, M.F., Nierenberg, D. et al. (1982) Disparate effects of heparin on free thyroxine measured by two different radioimmunoassays. J. Nucl. Med., 23, 507–10.
Bayer, M.F. and McDougall, I.R. (1984) Clinical assessment of a radioimmunoassay for free thyroxine using a modified tracer. J. Nucl. Med., 25, 402–5.
Chopra, I.J., Van Herle, A.J., Teco, G.N.C. et al. (1980) Serum free thyroxine in thyroidal and non-thyroidal illnesses: comparison of measurements by radioimmunoassay, equilibrium dialysis and free thyroxine index. J. Clin. Endocrinol., Metab., 51, 135–43.
Hershman, J.M., Jones, C.M. and Bailey, A.L. (1972) Reciprocal changes in thyrotropin and free thyroxine produced by heparin. J. Clin. Endocrinol., Metab., 34, 574–9.
Utiger, R.D. (1965) Radioimmunoassay of plasma thyrotropin. J. Clin. Invest, 44, 1277–86.
Odell, W.D., Wilber, J.F. and Paul, W.E. (1965) Radioimmunoassay of thyrotropin in human serum. J. Clin. Endocrinol. Metab., 25, 1179–88.
Ridgway, E.C. (1988) Thyrotropin radioimmunoassay: birth, life and demise. Mayo Clin. Proc., 63, 1028–34.
Bayer, M.F., Kriss, J.P. and McDougall, I.R. (1985) Clinical experience with sensitive thyrotropin measurements. Diagnostic and therapeutic implications. J. Nucl. Med., 26, 1248–56.
Toft, A.D. (1988) Use of sensitive immunor-adiometric assay for thyrotropin in clinical practice. Mayo Clin. Proc., 63, 1035–42.
Hershman, J.M., Pekary, A.E., Smith, V.P. et al. (1988) Evaluation of five high-sensitivity American thyrotropin assays. Mayo Clin. Proc., 63, 1133–9.
Klee, G.G. and Hay, I.D. (1988) Sensitive thyrotropin assays: analytic and clinical performance criteria. Mayo Clin. Proc., 63, 1123–32.
Caldwell, G., Kellett, H.A., Gow, S.M. et al. (1985) A new strategy for thyroid function testing. Lancet, 1, 1117–19.
Blunt, S., Woods, CA., Joplin, G.F. et al. (1988) The role of a highly sensitive amplified enzyme immunoassay for thyrotropin in the evaluation of thyrotroph function in hypopi-tuitary patients. Clin. Endocrinol., 29, 387–93.
Utiger, R.D. (1988) Thyrotropin measur-ments: past, present and future. Mayo Clin. Proc., 63, 1053–6.
Makoviak, J.A., McDougall, I.R., Bayer, M.F. et al. (1987) Significance of thyroid dysfunction in human cardiac allograft procurement. Transplantation, 43, 824–6.
Bayer, M.F., Makoviak, J.A., McDougall, I.R. (1987) Diagnostic performance of sensitive measurements of thyrotropin during severe non-thyroidal illness: their role in the diagnosis of hyperthyroidism,. Clin. Chem., 33; 2178–84.
Schally, A.V. (1978) Aspects of hypothalamic regulation of the pituitary gland (Nobel Prize lecture December 1977). Science, 202, 18–28.
Guillemin, R. (1978) Peptides in the brain: the new endocrinol of the neurone (Nobel Prize lecture December 1977). Science, 202; 390–402.
Ormston, B.J. Garry, R., Cryer, R.J. et al. (1971) Thyrotrophin-releasing hormone as a thyroid-function test. Lancet, 2, 10–14.
Fleischer, N., Lorente, M., Kirkland, J. et al. (1972) Synthetic thyrotropin releasing factor as a test of pituitary thyrotropin reserve. J. Clin. Endocrinol Metab., 34, 617–24.
Jackson, I.M.D. (1982) Thyrotropin-releasing hormone. N. Engl. J. Med., 306, 145–55.
Snyder, P.J. and Utiger, R.D. (1972) Response to thyrotropin-releasing hormone (TRH) in normal man. J. Clin. Endocrinol. Metab., 34, 380–5.
Borowski, G.D., Garofano, C.D., Rose, L.I. et al. (1984) Blood pressure response to thyrotropin releasing hormone in euthyroid subjects. J. Clin. Endocrinol. Metab., 58, 197–200.
Loosen, P.T. (1988) Thyroid function in affective disorders and alcoholism. Neurol. Clinics, 6, 55–82.
Hamilton, J.G. and Soley, M.H. (1939) Studies in iodine metabolism by use of a new radioactive isotope of iodine. Am. J. Physiol., 127;557–72.
Hamilton, J.G. and Soley, M.H. (1940) Studies in iodine metabolism of the thyroid gland in situ by use of radioiodine in normal subjects and in patients with various types of goiters. Am. J. Physiol., 131, 135–43.
Jaffe, H.I. and Ottoman, R.E. (1950) Evaluation of radioiodine test for thyroid function. JAMA, 143, 515–19.
Vanderlaan, W.P. (1957) Accumulation of radioactive iodine. N. Engl. J. Med., 257, 752–6.
Pittman, J.A., Dailey, G.E. and Beschi, R.J. (1969) Changing normal values for thyroidal radioiodine uptake. N. Engl. J. Med., 280, 1431–4.
Bernard, J.D., McDonald, R.A. and Nesmith, J.A. (1970) New normal ranges for the radioiodine uptake study. J. Nucl. Med., 11, 449–51.
Caplan, R.H. and Kujak, R. (1971) Thyroid uptake of radioactive iodine: a re-evaluation. JAMA, 215, 916–18.
Hooper, P.L. and Caplan, R.H. (1977) Thyroid uptake of radioactive iodine in hyperthyroidism. JAMA, 238, 411–13.
Atkins, H.L. (1971) Technetium-99m pertech-netate uptake and scanning in the evaluation of thyroid function. Semin. Nucl. Med., 1, 345–55.
Querido, A. and Stanbury, J.B. (1950) The response of the thyroid to thyrotropic hormone as an aid in the differential diagnosis of primary and secondary hypothyroidism. J. Clin. Endocrinol., Metab., 10, 1192–201.
Krishnamurthy, G.T. (1978) Human reaction to bovine TSH: concise communication. J. Nucl. Med., 19, 284–6.
Al-Aid, M.A., Al-Attar, R.A. and Al Hindawi Ay (1987) Clinical utility of a simple physical technique in thyroid scintigraphy. Eur. J. Nucl. Med., 13, 443–5.
Werner, S.C. and Spooner, M. (1955) A new and simple test for hyperthyroidism employing L-triiodothyronine and the 24 hourI-131 uptake method. Bull New York Acad. Med., 31, 137–45.
Oddie, T.H., Rundle, F.F., Thomas, I.D. et al. (1960) Quantitative observations with the thyroxine suppression test of thyroid function. J. Clin. Endocrinol Metab., 20, 1146–57.
Greer, M.A. and Smith, G.E. (1954) Method for increasing the accuracy of the radioiodine uptake as a test for thyroid function by the use of dessicated thyroid. J. Clin. Endocrinol. Metab., 14, 1374–84.
Alexander, W.D., Harden, R. McG., Schim-mins, J. et al. (1967) Treatment of thyrotoxicosis based on thyroidal suppressibility. Lancet, 2, 681–8.
Morgans, M.E. and Trotter, W.R. (1957) Defective organic binding of iodine by the thyroid in Hashimoto’s thyroiditis. Lancet, 1, 553–5.
McGirr, E.M. and Greig, W.R. (1968) Genetics and the thyroid. Medicine Today, 2, 21–8.
Silver, S. (1968) The thyroid gland and 131I, in Radioactive Nuclides in Medicine and Biology, Lea and Febiger, Philadelphia, pp. 1–143.
Klopowitz, J.M. and Solomon, D.H. (1971) Tests of thyroid function, in Nuclear Medicine, (2nd edn), (ed. W.H. Blahd), McGraw Hill, New York, pp. 175–226.
Wolff, J. (1969) Iodide goiter and the pharmacological effects of excess iodide. Am. J. Med., 47, 101–24.
Floyd, S.C., Beierwaltes, W.H., Odoson, V.N. et al. (1960) Defective iodination of tyrosine a cause of nodular goiter? J. Clin. Endocrinol. Metab., 20, 881–8.
Baschieri, L., Benedetti, G., De Luca, F. et al. (1963) Evaluation and limitations of the perchlorate test in the study of thyroid function. J. Clin. Endocrinol. Metab., 23, 786–91.
Stewart, R.D.H. and Murray, I.P.C. (1966) An evaluation of the perchlorate discharge test. J. Clin. Endocrinol. Metab., 26, 1050–8.
Trotter, W.R. (1962) Diseases of the Thyroid, 1st edn, F.A. Davis Co, Philadelphia, pp. 168–70.
Gray, H.W., Hooper, L.A. and Greig, W.R. (1973) An evaluation of the twenty-minute perchlorate discharge test. J. Clin. Endocrinol. Metab., 37, 351–5.
Cassen, B., Curtis, L., Reed, C. et al. (1951) Instrumentation for I131 use in medical studies. Nucleonics, 9, 46–50.
Allen, H.C. Jr., Goodwin, W.E. (1952) The scintillation counter as an instrument for the in vivo determination of thyroid weight. Radiology, 58, 68–79.
Bauer, F.K., Goodwin, W.E., Barrett, T.F. et al. (1952) Scintigrams of the thyroid gland. Calif. Med., 77, 380–2.
Hurley, P.J., Strauss, H.W., Pavoni, P. et al. (1971) The scintillation camera with pinhole collimator in thyroid imaging. Radiology, 101, 133–4.
Sostre, S., Ashare, A.B., Quinones, J.D. et al. (1978) Thyroid scintigraphy: pinhole images versus rectilinear scan. Radiology, 129, 759–62.
McDougall, I.R. and Kriss, J.P. (1976) Which radioisotope for diagnosis of thyroid disorders? Clin. Nucl. Med., 2, 235–8.
Ripley, S.D., Freitas, J.E. and Nagle, C.E. (1984) Is thyroid scintigraphy necessary beforeI-131 therapy for hyperthyroidism? Concise communication. J. Nucl. Med., 25, 664–7.
Ashkar, F.S. (1981) Thyroid imaging and function studies. Clin. Nucl. Med., 6, 77–86.
Datz, F.L. (1987) Gamuts in Nuclear Medicine, Appleton & Large, Norwalk.
Freitas, J.E., Gross, M.D. and Ripley, S. (1985) Radionuclide diagnosis and therapy of thyroid cancer: current status report. Semin. Nucl. Med., 15, 106–31.
Nelson, R.L., Wahner, H.W. and Gorman, C.A. (1978) Rectilinear thyroid scanning as a predictor of malignancy. Ann. Intern. Med., 88, 41–4.
O’Holleran, L.W., O’Holleran, T.P., Mills, G.Q. et al. (1982) Use of thyroid scans in the selection of surgical patients. Am. J. Surg., 144, 639–40.
Karelitz, J.R. and Richards, J.B. (1974) Necessity of oblique views in evaluating functional status of a thyroid nodule. J. Nucl. Med., 15, 782–5.
Nagai, G.R., Pitts, W., Basso, L. et al. (1987) Scintigraphic ‘hot nodules’ and thyroid cancer. Clin. Nucl. Med., 12, 123–7.
Fukata, S., Tamai, W., Matsubayashi, S. et al. (1987) Thyroid cancer and hot nodule. Eur. J. Nucl. Med., 13, 313–14.
Sandler, M.P., Fellmeth, B., Salhany, K.E. et al. (1988) Thyroid carcinoma masquerading as a benign hyperfunctioning nodule. Clin. Nucl. Med., 13, 410–15.
Shambaugh, G.E., Quinn, J.L., Oyasu, R. et al. (1974) Disparate thyroid imaging. JAMA, 228, 866–9.
Erjavec, M., Movrin, T., Auerspere, M. et al. (1977) Comparative accumulation of 99mTC and 131I in thyroid nodules: case report. J. Nucl. Med., 18, 346–7.
Barth, J.D., Bakker, W.H., Henneman, G. et al. (1978) Discrepancies between iodine and technetium thyroid scintigraphy. JAMA, 240, 463–4.
Hirabayashi, S., Koga, Y., Kitahara, T. et al. (1975) Inconsistent images of thyroid nodule scintigrams made with iodine and pertech-nate: case report. J. Nucl. Med., 16, 918.
Turner, J.W. and Spencer, R.P. (1976) Thyroid carcinoma presenting as a pertechnetate ‘hot’ nodule, but without 131I uptake: case report. J. Nucl. Med., 17, 22–3.
Wellman, H.N. and Anger, R.T. Jr. (1971) Radioiodine dosimetry and the use of radioiodines other then 131I in thyroid diagnosis. Semin. Nucl. Med., 1, 356–78.
Task force on short-lived radionuclides for medical applications. Evaluation of diseases of the thyroid gland with the in vivo use of radionuclides. J. Nucl. Med., 19, 107–12.
Vieras, F. (1983) Preoperative scintigraphic detection of cervical metastasis from thyroid carcinoma with technetium-99m pertechnetate. Clin. Nucl. Med., 10, 567–9.
Nakayama, A.C., Nakaja, H., Zeze, F. et al. (1987) Thyroid cancer with a high 123I-Nal uptake in primary and metastatic foci with euthyroidism. Eur. J. Nucl. Med., 13, 480–1.
Chen, J.S., La France, N.D., Rippin, R. et al. (1988) Iodine-123 SPECT of the thyroid in multinodular goiter. J. Nucl. Med., 29, 110–13.
Goldman, J.M., Line, B.R., Aamodt, R.L. et al. (1980) Influence of triiodothyronine withdrawal time on 131I uptake postthyroidec-tomy for thyroid cancer. J. Clin. Endocrinol. Metab., 50, 734–9.
Rosenbaum, R.C., Johnston, G.S., Valente, W.A. (1988) Frequency of hepatic visualisation during I—131 imaging for metastatic thyroid cancer. Clin. Nucl. Med., 13, 657–60.
Hoschl, R., Choy, D.H-L. and Gandevia, B. (1988)Iodine-131 uptake in inflammatory lung disease: a pitfall in treatment of thyroid carcinoma. J. Nucl. Med., 29, 701–6.
Brachman, M.B., Rothman, B.J., Ramanna, L. et al. (1988) False-positive iodine-131 body scan caused by a large renal cyst. Clin. Nucl. Med., 13, 416–18.
Lakshmanan, M., Schaffer, A., Robbins, J. et al. (1988) A simplified low iodine diet inI-131 scanning and therapy of thyroid cancer. Clin. Nucl. Med., 12, 866–8.
Khammash, N.F., Halkar, R.K., Abdel-Dayem, H.M. (1988) The use of technetium-99m pertechnetate in postoperative thyroid carcinoma. A comparative study with iodine-131. Clin. Nucl. Med., 16, 17–22.
Hoffer, P. (1980) Gallium mechanisms. J. Nucl. Med., 21, 282–5.
Hoffer, P. (1980) Gallium and infection. J. Nucl. Med., 21, 484–8.
Tsan, M-F. (1985) Mechanism of gallium-67 accumulation in inflammatory lesions. J. Nucl. Med., 26, 88.
Higashi, T., Ito, K., Mimura, T. et al. (1987) Clinical evaluation of 67Ga scanning in the diagnosis of anaplastic carcinoma and malignant lymphoma. Radiology, 141, 491–7.
Seder, J., Shimshak, R. and Williams, R. (1979) Reversible 67Ga citrate uptake in the thyroid with subacute thyroiditis. Clin. Nucl. Med., 4, 158–60.
Machac, J., Nejatheim, M. and Goldsmith, S.J. (1985) Gallium citrate uptake in crytococ-cal thyroiditis in a homosexual man. J. Nucl. Med. All. Sci., 29, 283–5.
Soin, J.S. (1987) Quantitative estimation of 67Ga citrate in hypofunctioning thyroid nodules. Radiology, 122, 243–5.
Ling, M.C.C., Dake, M.D. and Okerlund, M.D. (1988) Gallium uptake in the thyroid gland in amiodarone-induced hyperthyroidism. Clin. Nucl. Med., 13, 258–9.
Moreno, A.J., Brown, J.M., Salinas, J. A et al. (1984) Ga-67 positivity in sarcoidosis of the skin with coincident thyroid uptake of uncertain etiology. Clin. Nucl. Med., 9, 165–6.
Moreno, A.J., Brown, J.M., Spicer, M.J. et al. (1985) Thyroid localization of Ga-67 citrate. Semin. Nucl Med., 15, 224–5.
Allard, J.C., Lee, V.W. and Franklin, P. (1988) Thyroid uptake of gallium in Graves’ disease. Clin. Nucl. Med., 16, 663–6.
Fukuchi, M., Tachibana, K., Nishikawa, A. et al. (1978) Thallium-imaging in thyroid carcinoma — appearance of a lymph-node metastasis. J. Nucl. Med., 19, 195–6.
Tonami, N. and Hisada, K. (1980) 201T1 scintigraphy in post operative detection of thyroid cancer: comparative study with I. Radiology, 136, 461–4.
Brendel, A.J. Guyot, M., Lefort, G. et al. (1988) Thallium-201 imaging in the follow-up of differentiated thyroid carcinoma. J. Nucl. Med., 29, 1515–20.
Corstens, F., Huysmans, D. and Kloppen-berg, P. (1988) Thalium-201 scintigraphy of the suppressed thyroid: an alternative for iodine-123 scanning after TSH stimulation. J. Nucl Med., 29, 1360–3.
Hoefnagel, C.A., Delprat, C.C., Zanin, D. et al. (1988) New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma. Clin. Nucl. Med., 16, 159–65.
Keeling, C.A. and Basso, L.V. (1988) Iodine-131 MIBG uptake in metastatic medullary carcinoma of the thyroid. Clin. Nucl. Med., 16, 260–3.
James, E.M. and Charboneau, J.W. (1985) High-frequency (10 MHz) thyroid ultrasonography. Semin. Ultrasound CT MR, 6, 294–309.
Blum, M. (1986) Ultrasonography and computed tomography of the thyroid gland, in Werner’s The Thyroid, 5th edn, (eds S.H. Ing-bar and L.E. Braverman) Lippincott Company, Philadelphia, pp. 576–91.
Simeone, J.F., Daniels, G.H., Mueller, P.R. et al. (1982) High-resolution real-time sonography of the thyroid, Radiol., 145, 431–5.
Hammer, M., Wortsman, J. and Folse, R. (1982) Cancer in cystic lesions of the thyroid. Arch. Surg., 117, 1020–3.
Walker, J., Findlay, D., Amar, S.S. et al. (1985) A prospective study of thyroid ultrasound scan in the clinically solitary thyroid nodule. Br. J. Radiol., 58, 617–19.
Carroll, B. (1980) Personal communication.
Hoffer, P.B., Jones, W.D., Crawford, R.B., et al. (1968) Fluorescent thyroid scanning. A new method of imaging the thyroid. Radiology, 90, 342–4.
Hoffer, P.B. and Gottschalk, A. (1971) Fluorescent thyroid scanning. Scanning without radioisotopes. Initial clinical results. Radiology., 99, 117–23.
Patton, J.A. and Sandler, M.P. (1986) X-ray fluorescent scanning, in Thyroid and Parathyroid Imaging, (eds M.P. Sandler, J.A. Patton and C.L. Partain), Appleton-Century-Crofts, Norwalk, Conn., pp. 247–74.
Meignan, M. and Galle, P. (1980) Principles and clinical application of thyroid scanning with x-ray fluorescence. Clin. Nucl. Med., 5, 71–80.
Patton, J.A., Hollifield, J.W., Brill, A.B. et al. (1976) Differentiation between malignant and benign solitary thyroid nodules by fluorescent scanning. J. Nucl. Med., 17, 17–21.
Johnson, P.M., Esser, P.D. and Lister, D.B. (1979) Fluorescent thyroid imaging. Clinical evaluation of an alternative instrument. Radiology, 130, 219–22.
Silverman, P.M., Neuman, G.E., Korobkin, M. (1984) Computed tomography in the evaluation of thyroid disease. AJR, 142, 897–902.
Binder, R.E., Pugatch, R.D. and Faling, L.J. (1980) Diagnosis of posterior mediastinal goiter by computed tomography. J. Computer Assist. Tomograph.4, 550–2.
Bashist, B., Ellis, K. and Gold, R.P. (1983) Computed tomography of intrathoracic goiters. AJR, 140, 455–60.
Enzmann, D.R., Donaldson, S.S. and Kriss, J.P. (1979) Appearance of Graves’ disease on orbital computed tomography. J. Computer Assist. Tomograph, 3, 815–19.
Sandler, M.P., Patton, J.A., Sacks, G.A. et al. (1984) Evaluation of intrathoracic goiter with 1–123 scintigraphy and nuclear magnetic resonance imaging. J. Nucl. Med., 25, 874–6.
Smith, F.W., Runge, V.M., Sandler, M.P. et al. (1986) Magnetic resonance imaging in thyroid disease, in Thyroid and Parathyroid Imaging, (eds M.P. Sandler, J.A. Patton and C.L. Partain), Appleton-Century-Crofts, Norwalk, Conn., pp. 333–49.
Einhorn, J. and Franzen, S. (1962) Thin-needle biopsy in the diagnosis of thyroid disease. Acta Radiol., 58, 321–5.
Crile, G.W. Jr and Hazard, J.B. (1951) Classification of thyroiditis with special reference to use of the needle biopsy. J. Clin. Endocrinol. Metab., 11, 1123–7.
Crile, G.W. Jr and Vickery, A.L. Jr (1952) Special uses of the Silverman needle in office practice and at operation. Am. J. Surg., 83, 83–5
Wang, C-A. and Vickery, A.L. Jr (1976) Needle biopsy of the thyroid. Surg. Gyn. Obstet., 143, 365–8.
Van Herle, A.J., Rich, P., Ljung, B.M.E. et al. (1982) The thyroid nodule. Ann. Intern. Med., 96, 221–32.
Blum, M. (1984) The diagnosis of the thyroid nodule using aspiration biopsy and cytology. Arch. Intern. Med., 144, 1140–42.
Katz, A.D. and Dunkleman, D. (1984) Needle aspiration of non-functioning parathyroid cysts. Arch. Surg., 119, 307–8.
Burch, W. (1983) Fine-needle aspiration biopsy of the thyroid gland. Ann. Intern. Med., 98, 1024–5.
Zajdela, A., Zillhardt, P. and Voillemot, N. (1987) Cytological diagnosis by fine needle sampling without aspiration. Cancer, 59, 1201–5.
Ashcraft, M.W. and Van Herle, A.J. (1981) Management of thyroid nodules II. Scanning techniques, thyroid suppressive therapy, and fine needle aspiration. Head and Neck Surg., 3, 297–322.
Walfish, P.G., Hazani, E., Strawbridge, H.T.G. et al. (1977) Combined ultrasound and needle aspiration cytology in the assessment and management of hypofunctioning thyroid nodule. Ann. Intern. Med., 87, 270–4.
Esselstyn, C.B. and Crile, G. Jr (1978) Needle aspiration and needle biopsy of the thyroid. World J. Surg., 2, 321–9.
Colacchio, T.A., LoGerfo, P. and Feind C.R. (1980) Fine needle cytologic diagnosis of thyroid nodules. Review and report of 300 cases. Am. J. Surg., 140, 568–71.
Miller, T.R., Abele, J.S. and Greenspan, F.S. (1981) Fine-needle aspiration biopsy in the management of thyroid nodules. West J. Med., 134, 198–205.
Prinz, R.A., O’Morchoe, P.J., Barbato, A.L. et al. (1983) Fine needle aspiration biopsy of thyroid nodules. Ann. Surg., 198, 70–3.
Ramacciotti, C.E., Pretorius, H.T., Chu, E. et al. (1984) Diagnostic accuracy and use of aspiration biopsy in the management of thyroid nodules. Arch. Intern. Med., 144, 1169–73.
Al-Sayer, H.M., Krukowski, Z.H. Williams, V.M.M. et al. (1985) Fine needle aspiration cytology in isolated thyroid swellings: a prospective two year evaluation. Br. Med. J., 290, 1490–2.
Boey, J., Hsu, C., Collins, R.J. et al. (1986) False-negative errors in fine-needle aspiration biopsy of dominant thyroid nodules: a prospective follow-up study. World J. Surg., 10, 623–30.
Silverman, J.F., West, R.L., Larkin, E.W. et al. (1986) The role of fine-needle aspiration biopsy in the rapid diagnosis and management of thyroid neoplasm. Cancer, 57, 1164–70.
Miller, J.M., Hamburger, J.I. and Kini, S.R. (1980) The impact of needle biopsy on the preoperative diagnosis of thyroid nodules. Henry Ford Hosp. Med. J., 28, 145–8.
Galvan, G. (1977) Thin needle aspiration biopsy and cytological examination of hypo-functional, ‘cold’ thyroid nodules in routine clinical work. Clin. Nucl. Med., 2, 413–21.
Gharib, H., Goellner, J.R., Zinsmeister, A.R. et al. (1984) Fine-needle aspiration biopsy of the thyroid. The problem of suspicious cytological findings. Ann. Intern. Med., 101, 25–8.
Khalifa, M.S., Nur, A., Al Sarrag, S. et al. (1988) Management of the solitary cold thyroid nodule: a prospective study. Int. Surg., 73, 99–101.
Boon, M.E., Lowhagen, T., Willems, J-S. (1980) Planimetric studies on fine needle aspirates of follicular adenoma and follicular carcinoma of the thyroid. Acta Cytologica, 24, 145–8.
Guarda, L.A. and Baskin, H.J. (1987) Inflammatory and lymphoid lesions of the thyroid gland. Cytopathology by fine-needle aspiration. Am. J. Clin. Pathol., 87, 14–22.
Watts, N.B. (1987) Carcinoma metastatic to the thyroid: Prevalence and diagnosis by fine-needle aspiration cytology. Am. J. Med. Sci., 293, 13–17.
Asp, A.A., Georgitis, W., Waldron, E.J. et al. (1987) Fine needle aspiration of the thyroid. Use in an average health care facility. Am. J. Med., 83, 489–93.
Bayer, M.F. and McDougall, I.R. (1980) Follow-up of patients with differentiated thyroid cancer using thyroglobulin measured by an immunoradiometric assay. Comparison withI-131 total body scans. J. Nucl. Med., 21, 741–4.
Bayer, M.F. and Kriss, J.P. (1979) Immunoradiometric assay for serum thyroglobulin: semiquantitative measurement of thyroglobulin in antithyroglobulin-positive serum. J. Clin. Endocrinol. Metab., 49, 557–64.
Bayer, M.F. and Kriss, J.P. (1979) A solid phase, sandwish-type radioimmunoassay for antithyroglobulin: elimination of false positive results and semiquantitative measurement of antithyroglobulin in the presence of elevated thyroglobulin. J. Clin. Endocrinol. Metab., 49, 565–71.
Bayer, M.F., McDougall, I.R. (1984) Differences in radioimmunoassay results for thyroglobulin that affect management of patients with thyroid cancer. Clin. Chem., 30, 81–6.
Van Herle, A.J. and Uller, R.P. (1975) Elevated serum thyroglobulin: a marker of metastases in differentiated thyroid carcinomas. J. Clin. Invest., 56, 272–7.
Shlossberg, A.H., Jacobson, J.C.J., and Ibbert-son, H.K. (1979) Serum thyroglobulin in the diagnosis and management of thyroid carcinoma. Clin. Endocrinol., 10, 17–27.
Tang Fui, S.C.N. Hoffenberg R., Maisey, M.N. et al. (1979) Serum thyroglobulin concentrations and whole-body radioiodine scan in follow-up of differentiated thyroid cancer after thyroid ablation. Br. Med. J., 2, 298–300.
Charles, M.A., Dodson, L.E., Waldeck, N. et al. (1980) Serum thyroglobulin levels predict total body iodine scan findings in patients with treated well-differentiated thyroid carcinoma. Am. J. Med., 69, 401–7.
Blahd, W.H., Drickman, M.V., Porter, C.W. et al. (1984) Serum thyroglobulin, a monitor of differentiated thyroid carcinoma in patients receiving thyroid hormone suppression therapy: concise communication. J. Nucl. Med., 25, 673–7.
Black, E.G., Cassoni, A., Gimlette, T.M.D. et al. (1981) Serum thyroglobulin in thyroid cancer. Lancet, 2, 443–5.
Bayer, M.F., McDougall, I.R. and Kriss, J.P. (1987) Retrospective study of serum thyroglobulin measurements performed in patients with differentiated thyroid carcinoma at the Standford University thyroid clinic between 1979 and 1985, in Thyroglobulin and Thyroglobulin Antibodies in the Follow-up of Thyroid Cancer and Endemic Goiter, (eds M. Hufner and C. Reiners), George Thieme Verlag, Stuttgart, pp. 104–11.
Coakley, A.J., Page, C.J., Gaunt, J. et al. (1982) Whole body counting and thyroglobulin levels in assessment of thyroid carcinoma, in Nuclear Medicine and Biology: Proceedings of Third World Congress Nuclear Medicine and Biology, Paris, (ed. C. Raynaud) Pergamon Press.
Moser, E., Fritsch, S. and Braun, S. (1988) Thyroglobulin and 131I uptake of remaining thyroid tissue in patients with differentiated carcinoma after thyroidectomy. Nucl. Med. Comm., 9, 262–6.
Miller, J.H. and Marcus, C.S. (1988) Metastatic papillary thyroid carcinoma with normal serum thyroglobulin level. Clin. Nucl. Med., 16, 652–3.
Levine, G.A., Hershman, J.M., Van Herle, A.J. et al. (1978) Thyroglobulin and calcitonin in patients with nontoxic goiter. JAMA, 240, 2282–3.
Lo Gerfo, P., Colacchio, T., Colacchio, D. et al. (1979) Thyroglobulin in benign and malignant thyroid disease. JAMA, 241, 923–5.
Schneider, A.B., Favus, M.J., Stachura, M.E. et al. (1977) Plasma thyroglobulin in detecting thyroid carcinoma after childhood head and neck irradiation. Ann. Intern. Med., 86, 29–34.
Roitt, I.M., Doniach, D., Campbell, P.N. et al. (1956) Autoantibodies in Hashimoto’s disease (lymphadenoid goitre). Lancet, 2, 820–1.
Mori, T. and Kriss, J.P. (1971) Measurement by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves’ disease and other thyroid disorders. J. Clin. Endocrinol. Metab., 33, 688–98.
Mariotti, S., Russova, A., Pissani, S. et al. (1982) A new solid-phase immunoradiometric assay for anti-thyroglobulin autoantibody. J. Endocrinol. Invest., 5, 227–33.
Lundstrom, B., Hed, J., Johansson, K-E. et al. (1977) Thyroid function after subtotal thyroidectomy for hyperthyroidism related to some morphological and immunological features. Acta Chir. Scand., 143, 215–20.
Adams, D.D. and Purves, H.D. (1956) Abnormal responses in the assay of thyro-trophin. Proc. Univ. Otago Med. School, 34, 11–12.
Rappaport, B. (1987) Autoimmune mechanisms in thyroid disease, in The Thyroid, (ed. W.L. Green), Elsevier, New York, pp. 47–106.
Rees-Smith B. (1988) Autoantibodies to the thyrotropin receptor. Endocrine Review, 9, 106–21.
Dumont, J.E., Roger, P.P. and Ludgate, M. (1987) Assays for thyroid growth immunoglobulins and their clinical implications: methods, concepts and misconceptions. Endocrine Reviews, 8, 448–52.
Multiple authors (1988) Various personal recollections of scientists reposible for important discoveries in the field of thyroid autoimmunity. Autoimmunity, Volume1, Gordon and Breach Science Publishers Inc. Great Britain (Reprints available directly from the publisher.)
Tashjian, A.H. Jr. Howland, B.G., Melvin K.E.W. et al. (1970) Immunoassay of human calcitonin: clinical measurement, relation to serum calcium and studies in patients with medullary cancer. N. Engl. J. Med., 283, 890–5.
Jackson, C.E., Tashjian, A.H. Jr and Miller, H.H. (1973) Detection of medullary cancer by calcitonin assay in families. Ann. Intern. Med., 78, 845–52.
Wells, S.A., Dilley, W.G., Farndon, J.A. et al. (1985) Early diagnosis and treatement of medullary thyroid carcinoma. Arch. Intern. Med., 145, 1248–52.
Boothby, W.M. (1919) The value of the basal metabolic rate in the treatment of diseases of the thyroid. Med. Clin. North Amer., 3, 603–18.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1992 I. Ross McDougall
About this chapter
Cite this chapter
McDougall, I.R. (1992). Tests of thyroid function. In: Thyroid Disease in Clinical Practice. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2881-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2881-8_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-19-520936-5
Online ISBN: 978-1-4899-2881-8
eBook Packages: Springer Book Archive